Suven Life Sciences Ltd (SUVP)

Currency in INR
250.80
-13.20(-5.00%)
Closed·
SUVP Scorecard
Full Analysis
Impressive gross profit margins
SUVP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
250.80263.90
52 wk Range
102.50299.99
Key Statistics
Bid/Ask
250.80 / 250.80
Prev. Close
264
Open
263.9
Day's Range
250.8-263.9
52 wk Range
102.5-299.99
Volume
159.96K
Average Volume (3m)
899.57K
1-Year Change
83.76%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SUVP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High return over the last year

Suven Life Sciences Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Suven Life Sciences Ltd Company Profile

Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities in central nervous system diseases. Its product candidates include Masupirdine (SUVN-502) for the treatment of Alzheimer disease and neuropsychiatric symptoms; Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist for treating sleep and cognitive disorders; and Ropanicant (SUVN-911), an Alpha4Beta2 nAChRs receptor antagonist for the treatment of depressive disorders. The company is also developing Usmarapride (SUVN-D4010), a bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for treating cognitive disorders; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for treating gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is based in Hyderabad, India. Suven Life Sciences Limited operates as a subsidiary of Jasti Property and Equity Holdings Private Limited.

Employees
138
Market
India

Compare SUVP to Peers and Sector

Metrics to compare
SUVP
Peers
Sector
Relationship
P/E Ratio
−34.0x60.3x−0.5x
PEG Ratio
0.640.640.00
Price/Book
49.7x3.7x2.6x
Price / LTM Sales
820.9x5.6x3.3x
Upside (Analyst Target)
-17.0%43.5%
Fair Value Upside
Unlock−4.6%6.8%Unlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-2.02 / --
Revenue / Forecast
26.90M / --
EPS Revisions
Last 90 days

SUVP Income Statement

People Also Watch

271.80
ADTB
-2.28%
384.60
BAJE
-0.81%
195.75
LTFL
-2.26%
2,636.70
MAZG
-5.32%

FAQ

What Stock Exchange Does Suven Life Sciences Ltd Trade On?

Suven Life Sciences Ltd is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Suven Life Sciences Ltd?

The stock symbol for Suven Life Sciences Ltd is "SUVP."

What Is the Suven Life Sciences Ltd Market Cap?

As of today, Suven Life Sciences Ltd market cap is 54.69B.

What Is Suven Life Sciences Ltd's Earnings Per Share (TTM)?

The Suven Life Sciences Ltd EPS (TTM) is -7.37.

When Is the Next Suven Life Sciences Ltd Earnings Date?

Suven Life Sciences Ltd will release its next earnings report on 03 Nov 2025.

From a Technical Analysis Perspective, Is SUVP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Suven Life Sciences Ltd Stock Split?

Suven Life Sciences Ltd has split 1 times.

How Many Employees Does Suven Life Sciences Ltd Have?

Suven Life Sciences Ltd has 138 employees.

What is the current trading status of Suven Life Sciences Ltd (SUVP)?

As of 09 Aug 2025, Suven Life Sciences Ltd (SUVP) is trading at a price of 250.80, with a previous close of 264.00. The stock has fluctuated within a day range of 250.80 to 263.90, while its 52-week range spans from 102.50 to 299.99.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.